about
Orbital radiotherapy for adult thyroid eye diseaseQuercetin inhibits IL-1β-induced inflammation, hyaluronan production and adipogenesis in orbital fibroblasts from Graves' orbitopathy.Novel anti-adipogenic activity produced by human fibroblasts.The aryl hydrocarbon receptor ligand ITE inhibits TGFβ1-induced human myofibroblast differentiationPeroxisome proliferator-activated receptor gamma ligands inhibit transforming growth factor-beta-induced, hyaluronan-dependent, T cell adhesion to orbital fibroblasts.Salinomycin and other polyether ionophores are a new class of antiscarring agentThy1 (CD90) controls adipogenesis by regulating activity of the Src family kinase, FynNormal Human Lung Epithelial Cells Inhibit Transforming Growth Factor-β Induced Myofibroblast Differentiation via Prostaglandin E2Development of Thyroid-Associated Ophthalmopathy in Patients Who Underwent Total Thyroidectomy.CD40 Expression in Fibrocytes Is Induced by TSH: Potential Synergistic Immune Activation.Inhibitory Effects of α-Lipoic Acid on Oxidative Stress-Induced Adipogenesis in Orbital Fibroblasts From Patients With Graves Ophthalmopathy.Thyroid-associated orbitopathy: Current insights into the pathophysiology, immunology and management.Regulation of Lymphocyte Function by PPARgamma: Relevance to Thyroid Eye Disease-Related InflammationOrbital fibroblasts from thyroid eye disease patients differ in proliferative and adipogenic responses depending on disease subtype.Fat circadian biologyThe orbital fibroblast: a key player and target for therapy in graves' ophthalmopathy.Selenium: an element for life.Pathogenesis of thyroid eye disease: review and update on molecular mechanisms.The Aryl Hydrocarbon Receptor and Its Ligands Inhibit Myofibroblast Formation and Activation: Implications for Thyroid Eye Disease.Radiotherapy for Graves' disease. The possible role of low-dose radiotherapyOrbital Decompression for Thyroid Eye Disease.Mast cell-derived prostaglandin D2 controls hyaluronan synthesis in human orbital fibroblasts via DP1 activation: implications for thyroid eye disease.Immunoglobulin G4-positive staining of orbital lesions in thyroid eye disease: Report of two cases.Changes of orbital tissue volumes and proptosis in patients with thyroid extraocular muscle swelling after methylprednisolone pulse therapy.CD40 ligand induces expression of vascular cell adhesion molecule 1 and E-selectin in orbital fibroblasts from patients with Graves' orbitopathy.Biomarker identification of thyroid associated ophthalmopathy using microarray data
P2860
Q24201984-09E788FD-314F-4020-909E-E7E7B0DAF635Q34062319-733A54E1-3727-4767-8AC3-4426CDA1F0E2Q34149741-D20E9ABB-7649-4E76-91DE-5CF96DA937D9Q34805707-4E43F787-F013-4004-BC9F-D231FA582209Q34998187-165BF39E-F2E7-4FCB-AA9A-B4E145C20C38Q35055573-1CB7BD5C-1CD6-491B-93B1-96F59537D1C3Q35576492-99FEEA2A-91EA-4997-9DCE-0FB0EE69D172Q35738996-1A4E2B57-4141-49A7-AED9-C323F0413C5FQ35971151-DBE4E45C-5890-4CF6-8E2A-D98A22A6CE5FQ36133982-62539C21-4BBA-402C-8D56-DC079085AC3CQ36478242-82A1D8B9-B1BA-43EF-93BB-F1F0326EC8DAQ37060528-CF5809D6-4C07-4FBF-B438-DE6AA47FCEEEQ37114625-9E49E560-DE5B-4628-8FD6-541478D01930Q37296579-92B77D17-FA11-4E9D-A7E8-963801C9390FQ37422118-253C241D-23D1-415A-A2EE-614E16A93E95Q37784810-4FC99D6F-70F1-4CCA-89B9-A716C80FDDF8Q38292241-D9408163-6956-4345-A150-F141A6606E94Q38633022-69C78495-7C2B-4A57-922C-2B7FEBA5B585Q38795531-7E7D3A89-3019-465C-B484-F2EB5835E34BQ38948145-A5F30380-BE74-490A-A465-F9FE66DC462AQ39159003-140B730A-35B9-432F-8BC3-9ECC76434B31Q40601963-8129D541-D3CC-4BC9-87E4-053D72913E7BQ52871558-C6CB9E34-4C72-40C8-8F02-286ECD346BA0Q53362208-132547FB-478D-4CA8-9ABD-D5F25B9B1ED8Q54177827-7D0B4E17-D95E-4188-9526-9CC9300B3657Q58728096-EC39A259-6C03-49D5-A580-7F8F621B4B22
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immune mechanisms in thyroid eye disease.
@en
Immune mechanisms in thyroid eye disease.
@nl
type
label
Immune mechanisms in thyroid eye disease.
@en
Immune mechanisms in thyroid eye disease.
@nl
prefLabel
Immune mechanisms in thyroid eye disease.
@en
Immune mechanisms in thyroid eye disease.
@nl
P2093
P2860
P356
P1433
P1476
Immune mechanisms in thyroid eye disease
@en
P2093
Geniece M Lehmann
Richard P Phipps
Steven E Feldon
P2860
P304
P356
10.1089/THY.2007.0407
P577
2008-09-01T00:00:00Z